According to a recently published report by Brisk Insights, the Global Angioedema Market is expected to grow at the CAGR of 6.7% during 2017-2025. The global angioedema market is segmented on the basis of treatment and geography. The report on global angioedema market (by treatment and geography) provides a detailed overview and predictive analysis of the market.
Full report available on Angioedema Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/angioedema-market
Market Insights
Rising numbers of angioedema patients is the key driver for global angioedema market. The treatment types include antihistamines, corticosteroids, autoimmune drugs, anti-fibrinolytic agents and blood protein controllers. Antihistamines and corticosteroids accounted for over 45% of the total market share because they are prescribed as the first line therapies and majorly used as supportive therapies and most accessible source of treatment across the globe. Despite the high cost of new treatment options in comparison to older therapies such as androgens and anti-fibrinolytic agents, they are popular with medical practitioner as it is very effective in the attenuation of the symptoms such as subcutaneous and abdominal swelling. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period. The global angioedema market is currently dominated by North America due to increasing number of angioedema patients, rising public awareness and early disease diagnosis and supportive reimbursement scenario. Asia Pacific is anticipated to be the fastest growing market for angioedema; the driving factors are lucrative investment opportunities to manufacturers of angioedema treatment drugs, increasing number of angioedema patients and developed healthcare infrastructure.
Scope of the report
1. Global Angioedema Market, by Treatment, 2015–2025 ($ Millon)
1.1. Antihistamines
1.2. Corticosteroids
1.3. Autoimmune drugs
1.4. Anti-fibrinolytic agents
1.5. Blood protein controllers
1.2. Corticosteroids
1.3. Autoimmune drugs
1.4. Anti-fibrinolytic agents
1.5. Blood protein controllers
2. Global Angioedema Market, by Geography, 2015-2025 ($ Millon)
2.1. North America
2.1.1. U.S.
2.1.2. Canada
2.2. Europe
2.2.1. U.K.
2.2.2. Germany
2.2.3. France
2.2.4. Rest of Europe
2.3. Asia Pacific
2.3.1. Japan
2.3.2. China
2.3.3. Rest of Asia Pacific
2.4. Latin America (LATAM)
2.4.1. Brazil
2.4.2. Mexico
2.4.3. Rest of Latin America
2.5. Middle East and Africa (MEA)
2.5.1. GCC
2.5.2. Rest of Middle East and Africa
2.1.1. U.S.
2.1.2. Canada
2.2. Europe
2.2.1. U.K.
2.2.2. Germany
2.2.3. France
2.2.4. Rest of Europe
2.3. Asia Pacific
2.3.1. Japan
2.3.2. China
2.3.3. Rest of Asia Pacific
2.4. Latin America (LATAM)
2.4.1. Brazil
2.4.2. Mexico
2.4.3. Rest of Latin America
2.5. Middle East and Africa (MEA)
2.5.1. GCC
2.5.2. Rest of Middle East and Africa
3. Company Profiles
3.1. AstraZeneca plc
3.2. F. Hoffmann-La Roche AG
3.3. Valeant Pharmaceuticals International
3.4. Merck & Co.
3.5. Dyax Corp.
3.6. CSL Behring
3.7. Pharming Group
3.8. ViroPharma
3.9. Other Notable Players
Request Sample: http://www.briskinsights.com/sample-request/5703.2. F. Hoffmann-La Roche AG
3.3. Valeant Pharmaceuticals International
3.4. Merck & Co.
3.5. Dyax Corp.
3.6. CSL Behring
3.7. Pharming Group
3.8. ViroPharma
3.9. Other Notable Players
About Us:
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions.
Contact Us:
Office 1094
109 Vernon House, Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Ph. No. +448081890034
Email: sales@briskinsights.com
Company: http://www.briskinsights.com
No comments:
Post a Comment